|
1
|
Kearney CJ, Vervoort SJ, Ramsbottom KM, Todorovski I, Lelliott EJ, Zethoven M, Pijpers L, Martin BP, Semple T, Martelotto L, Trapani JA, Parish IA, Scott NE, Oliaro J, Johnstone RW. SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells. Sci Adv 2021; 7:7/8/eabe3610. [PMID: 33608275 PMCID: PMC7895430 DOI: 10.1126/sciadv.abe3610] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Accepted: 01/05/2021] [Indexed: 05/08/2023]
Abstract
Multimodal single-cell RNA sequencing enables the precise mapping of transcriptional and phenotypic features of cellular differentiation states but does not allow for simultaneous integration of critical posttranslational modification data. Here, we describe SUrface-protein Glycan And RNA-seq (SUGAR-seq), a method that enables detection and analysis of N-linked glycosylation, extracellular epitopes, and the transcriptome at the single-cell level. Integrated SUGAR-seq and glycoproteome analysis identified tumor-infiltrating T cells with unique surface glycan properties that report their epigenetic and functional state.
Collapse
Affiliation(s)
- Conor J Kearney
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia
| | - Stephin J Vervoort
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia
| | - Kelly M Ramsbottom
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Izabela Todorovski
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Emily J Lelliott
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Magnus Zethoven
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Lizzy Pijpers
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Ben P Martin
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Timothy Semple
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Luciano Martelotto
- Centre for Cancer Research, University of Melbourne, Melbourne 3000, VIC, Australia
| | - Joseph A Trapani
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Ian A Parish
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Nichollas E Scott
- Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia
| | - Jane Oliaro
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia.
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| | - Ricky W Johnstone
- Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia
- Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
| |
Collapse
|